RT Journal Article SR Electronic T1 Loss of function mutation in ELF4 causes autoinflammatory and immunodeficiency disease in human JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2021.09.22.21263689 DO 10.1101/2021.09.22.21263689 A1 Sun, Gan A1 Qiu, Luyao A1 An, Yunfei A1 Ding, Yuan A1 Zhou, Lina A1 Wu, Junfeng A1 Tang, Xuemei A1 Xia, Huawei A1 Cao, Lili A1 You, Fuping A1 Zhao, Xiaodong A1 Du, Hongqiang YR 2021 UL http://medrxiv.org/content/early/2021/09/25/2021.09.22.21263689.abstract AB Monogenic autoinflammatory diseases (mAIDs) are a heterogeneous group of diseases affecting primarily innate immunity, with various specific genetic causes. Genetic diagnosis of mAIDs can assist in the patient’s management and therapy. However, a large number of sporadic and familial cases remain genetically uncharacterized. Here, we described a pediatric patient suffering from recurrent viral and bacterial respiratory infection, refractory oral ulcer and constipation, who was clinically diagnosed of inborn errors of immunity (IEI). In an effort to establish genetic diagnosis, no known causative genes were identified by whole-exome sequencing. However, manually going through bioinformatically predicted candidate genes, we suspected and prioritized ELF4 (chrX:129205133 A>G, c.691T>C, p.W231R) as the genetic cause for our patient. We then evaluated the pathogenicity of this mutation by both various bioinformatic methods and preliminary but definitive experimental approach. Our data suggested that W231R mutant ELF4 is a “loss of function” mutation causing decreased protein stability and decreased trans-activation activity. Thus, we identified a novel mAID, which we termed “X-linked autoinflammatory and immunodeficiency disease associated with ELF4, X-AIDE”.Competing Interest StatementThe authors have declared no competing interest.Funding StatementSanming Project of Medicine in Shenzhen (SZSM201812002); Livelihood Project of Chongqing, China (cstc2018jscxmsybX0005) National Natural Science Foundation of China (81974255)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The ethics committee of Children's Hospital of Chongqing Medical University approved the study. Blood samples collection were performed in accordance with the Declaration of Helsinki.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from the corresponding authors upon reasonable request.